Canaccord analyst Richard Close downgraded Oak Street Health (OSH) to Hold from Buy with a price target of $39, up from $29, after CVS Health (CVS) announced a deal to acquire Oak Street for $39 per share.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OSH:
- CVS Health says Oak Street Health deal has long term growth, earnings power
- Oak Street Health downgraded to In Line from Outperform at Evercore ISI
- Oak Street Health downgraded to Neutral from Overweight at Piper Sandler
- Oak Street Health downgraded to Hold from Buy at Stifel
- CVS Finally Confirms OSH Deal; Beats Q4 Expectations